GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Optomed PLC (OHEL:OPTOMED) » Definitions » EV-to-Revenue

Optomed (OHEL:OPTOMED) EV-to-Revenue : 7.12 (As of Jun. 16, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Optomed EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Optomed's enterprise value is €106.51 Mil. Optomed's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €14.95 Mil. Therefore, Optomed's EV-to-Revenue for today is 7.12.

The historical rank and industry rank for Optomed's EV-to-Revenue or its related term are showing as below:

OHEL:OPTOMED' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.3   Med: 4.09   Max: 15.61
Current: 7.12

During the past 9 years, the highest EV-to-Revenue of Optomed was 15.61. The lowest was 1.30. And the median was 4.09.

OHEL:OPTOMED's EV-to-Revenue is ranked worse than
85.29% of 666 companies
in the Healthcare Providers & Services industry
Industry Median: 1.8 vs OHEL:OPTOMED: 7.12

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-16), Optomed's stock price is €6.06. Optomed's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.91. Therefore, Optomed's PS Ratio for today is 6.63.


Optomed EV-to-Revenue Historical Data

The historical data trend for Optomed's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optomed EV-to-Revenue Chart

Optomed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 5.06 7.14 9.06 4.01 4.18

Optomed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.21 3.43 2.88 4.18 4.62

Competitive Comparison of Optomed's EV-to-Revenue

For the Health Information Services subindustry, Optomed's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optomed's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Optomed's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Optomed's EV-to-Revenue falls into.



Optomed EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Optomed's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=106.510/14.949
=7.12

Optomed's current Enterprise Value is €106.51 Mil.
Optomed's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €14.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optomed  (OHEL:OPTOMED) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Optomed's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6.06/0.914
=6.63

Optomed's share price for today is €6.06.
Optomed's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.91.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optomed EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Optomed's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Optomed (OHEL:OPTOMED) Business Description

Traded in Other Exchanges
Address
Yrttipellontie 1, Oulu, FIN, 90230
Optomed PLC is a Finnish health technology company and providers of handheld camera solutions. The company operates in two business segments that are Devices and Software. Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras, that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, glaucoma and AMD. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company operates in Finland, China, and other countries.

Optomed (OHEL:OPTOMED) Headlines

No Headlines